|
1
|
Venugopal JR, Prabhakaran MP, Mukherjee S,
et al: Biomaterial strategies for alleviation of myocardial
infarction. J R Soc Interface. 9:1–19. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Writing Group Members. Lloyd-Jones D,
Adams RJ, Brown TM, et al; American Heart Association Statistics
Committee and Stroke Statistics Subcommittee. Heart disease and
stroke statistics-2010 update: a report from the American Heart
Association. Circulation. 121:e46–e215. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grandi AM, Imperiale D, Santillo R, et al:
Aldosterone antagonist improves diastolic function in essential
hypertension. Hypertension. 40:647–652. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu JN, Chen R, Fu YH, et al: Smad3
inactivation and MiR-29b upregulation mediate the effect of
carvedilol on attenuating the acute myocardium infarction-induced
myocardial fibrosis in rat. PLoS One. 8:e755572013. View Article : Google Scholar
|
|
5
|
Fang L, Beale A, Ellims AH, et al:
Associations between fibrocytes and postcontrast myocardial T1
times in hypertrophic cardiomyopathy. J Am Heart Assoc.
2:e0002702013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rao AD, Shah RV, Garg R, et al:
Aldosterone and myocardial extracellular matrix expansion in type 2
diabetes mellitus. Am J Cardiol. 112:73–78. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Engebretsen KV, Lunde IG, Strand ME, et
al: Lumican is increased in experimental and clinical heart
failure, and its production by cardiac fibroblasts is induced by
mechanical and proinflammatory stimuli. FEBS J. 280:2382–2398.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma Y, Halade GV, Zhang J, et al: Matrix
metalloproteinase-28 deletion exacerbates cardiac dysfunction and
rupture after myocardial infarction in mice by inhibiting M2
macrophage activation. Circ Res. 112:675–688. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bai J, Zhang N, Hua Y, et al: Metformin
inhibits angiotensin II-induced differentiation of cardiac
fibroblasts into myofibroblasts. PLoS One. 8:e721202013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu D, Soleymani S, Madakshire R and Insel
PA: ATP released from cardiac fibroblasts via connexin hemichannels
activates profibrotic P2Y2 receptors. FASEB J. 26:2580–2591. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang W, Chancey AL, Tzeng HP, et al: The
development of myocardial fibrosis in transgenic mice with targeted
overexpression of tumor necrosis factor requires mast
cell-fibroblast interactions. Circulation. 124:2106–2116. 2011.
View Article : Google Scholar
|
|
12
|
Kapoun AM, Liang F, O’Young G, et al:
B-type natriuretic peptide exerts broad functional opposition to
transforming growth factor-beta in primary human cardiac
fibroblasts: fibrosis, myofibroblast conversion, proliferation, and
inflammation. Circ Res. 94:453–461. 2004. View Article : Google Scholar
|
|
13
|
Vilahur G, Juan-Babot O, Peña E, et al:
Molecular and cellular mechanisms involved in cardiac remodeling
after acute myocardial infarction. J Mol Cell Cardiol. 50:522–533.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He W, Zhang L, Ni A, et al: Exogenously
administered secreted frizzled related protein 2 (Sfrp2) reduces
fibrosis and improves cardiac function in a rat model of myocardial
infarction. Proc Natl Acad Sci USA. 107:21110–21115. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baum JR, Long B, Cabo C and Duffy HS:
Myofibroblasts cause heterogeneous Cx43 reduction and are unlikely
to be coupled to myocytes in the healing canine infarct. Am J
Physiol Heart Circ Physiol. 302:H790–H800. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Laeremans H, Hackeng TM, van Zandvoort MA,
et al: Blocking of frizzled signaling with a homologous peptide
fragment of wnt3a/wnt5a reduces infarct expansion and prevents the
development of heart failure after myocardial infarction.
Circulation. 124:1626–1635. 2011. View Article : Google Scholar
|
|
17
|
Novoyatleva T, Schymura Y, Janssen W, et
al: Deletion of Fn14 receptor protects from right heart fibrosis
and dysfunction. Basic Res Cardiol. 108:3252013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lian H, Ma Y, Feng J, et al:
Heparin-binding EGF-like growth factor induces heart interstitial
fibrosis via an Akt/mTor/p70s6k pathway. PLoS One. 7:e449462012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Wang Y, Liu Y, et al:
Krüppel-like factor 4 transcriptionally regulates TGF-β1 and
contributes to cardiac myofibroblast differentiation. PLoS One.
8:e634242013.
|
|
20
|
Zhao T, Zhao W, Chen Y, et al:
Platelet-derived growth factor-D promotes fibrogenesis of cardiac
fibroblasts. Am J Physiol Heart Circ Physiol. 304:H1719–H1726.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu J and Carver W: Effects of
interleukin-33 on cardiac fibroblast gene expression and activity.
Cytokine. 58:368–379. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gazdhar A, Fachinger P, van Leer C, et al:
Gene transfer of hepatocyte growth factor by electroporation
reduces bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol
Physiol. 292:L529–L536. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li F, Sun JY, Wang JY, et al: Effect of
hepatocyte growth factor encapsulated in targeted liposomes on
liver cirrhosis. J Control Release. 131:77–82. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kanemura H, Iimuro Y, Takeuchi M, et al:
Hepatocyte growth factor gene transfer with naked plasmid DNA
ameliorates dimethylnitrosamine-induced liver fibrosis in rats.
Hepatol Res. 38:930–939. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Herrero-Fresneda I, Torras J, Franquesa M,
et al: HGF gene therapy attenuates renal allograft scarring by
preventing the profibrotic inflammatory-induced mechanisms. Kidney
Int. 70:265–274. 2006. View Article : Google Scholar
|
|
26
|
Okayama K, Azuma J, Dosaka N, et al:
Hepatocyte growth factor reduces cardiac fibrosis by inhibiting
endothelial-mesenchymal transition. Hypertension. 59:958–965. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang ZJ, Chen B, Sheng Z, et al:
Improvement of heart function in postinfarct heart failure swine
models after hepatocyte growth factor gene transfer: comparison of
low-, medium- and high-dose groups. Mol Biol Rep. 37:2075–2081.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nakamura T, Matsumoto K, Mizuno S, et al:
Hepatocyte growth factor prevents tissue fibrosis, remodeling, and
dysfunction in cardiomyopathic hamster hearts. Am J Physiol Heart
Circ Physiol. 288:H2131–H2139. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takeda S, Liu H, Sasagawa S, et al:
HGF-MET signals via the MLL-ETS2 complex in hepatocellular
carcinoma. J Clin Invest. 123:3154–3165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tsou HK, Chen HT, Hung YH, et al: HGF and
c-Met interaction promotes migration in human chondrosarcoma cells.
PLoS One. 8:e539742013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma PC, Tretiakova MS, Nallasura V, et al:
Downstream signalling and specific inhibition of c-MET/HGF pathway
in small cell lung cancer: implications for tumour invasion. Br J
Cancer. 97:368–377. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee WJ, Wu LF, Chen WK, et al: Inhibitory
effect of luteolin on hepatocyte growth factor/scatter
factor-induced HepG2 cell invasion involving both MAPK/ERKs and
PI3K-Akt pathways. Chem Biol Interact. 160:123–133. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wen X, Li Y, Hu K, et al: Hepatocyte
growth factor receptor signaling mediates the anti-fibrotic action
of 9-cis-retinoic acid in glomerular mesangial cells. Am J Pathol.
167:947–957. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang H, Tang QZ, Wang AB, et al: Tumor
suppressor A20 protects against cardiac hypertrophy and fibrosis by
blocking transforming growth factor-beta-activated kinase
1-dependent signaling. Hypertension. 56:232–239. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ai W, Zhang Y, Tang QZ, et al: Silibinin
attenuates cardiac hypertrophy and fibrosis through blocking
EGFR-dependent signaling. J Cell Biochem. 110:1111–1122. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yan-Hong F, Hui D, Qing P, et al: Effects
of arginine vasopressin on differentiation of cardiac fibroblasts
into myofibroblasts. J Cardiovasc Pharmacol. 55:489–495.
2010.PubMed/NCBI
|
|
37
|
Yao J and Eghbali M: Decreased collagen
gene expression and absence of fibrosis in thyroid hormone-induced
myocardial hypertrophy. Response of cardiac fibroblasts to thyroid
hormone in vitro. Circ Res. 71:831–839. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu C, Cao F, Tang QZ, et al: Allicin
protects against cardiac hypertrophy and fibrosis via attenuating
reactive oxygen species-dependent signaling pathways. J Nutr
Biochem. 21:1238–1250. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cai J, Yi FF, Bian ZY, et al: Crocetin
protects against cardiac hypertrophy by blocking MEK-ERK1/2
signalling pathway. J Cell Mol Med. 13:909–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang X, Khaidakov M, Ding Z, et al: LOX-1
in the maintenance of cytoskeleton and proliferation in senescent
cardiac fibroblasts. J Mol Cell Cardiol. 60:184–190. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang K, Zhao X, Kuang C, et al:
Overexpression of SDF-1α enhanced migration and engraftment of
cardiac stem cells and reduced infarcted size via CXCR4/PI3K
pathway. PLoS One. 7:e439222012.
|
|
42
|
Yang J, Ii M, Kamei N, et al:
CD34+ cells represent highly functional endothelial
progenitor cells in murine bone marrow. PLoS One. 6:e202192011.
|
|
43
|
Fujita J, Mori M, Kawada H, et al:
Administration of granulocyte colony-stimulating factor after
myocardial infarction enhances the recruitment of hematopoietic
stem cell-derived myofibroblasts and contributes to cardiac repair.
Stem Cells. 25:2750–2759. 2007. View Article : Google Scholar
|
|
44
|
Adapala RK, Thoppil RJ, Luther DJ, et al:
TRPV4 channels mediate cardiac fibroblast differentiation by
integrating mechanical and soluble signals. J Mol Cell Cardiol.
54:45–52. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Galie PA, Russell MW, Westfall MV and
Stegemann JP: Interstitial fluid flow and cyclic strain
differentially regulate cardiac fibroblast activation via AT1R and
TGF-β1. Exp Cell Res. 318:75–84. 2012.PubMed/NCBI
|
|
46
|
Fan YH, Dong H, Pan Q, et al: Notch
signaling may negatively regulate neonatal rat cardiac
fibroblast-myofibroblast transformation. Physiol Res. 60:739–748.
2011.
|
|
47
|
Melchior-Becker A, Dai G, Ding Z, et al:
Deficiency of biglycan causes cardiac fibroblasts to differentiate
into a myofibroblast phenotype. J Biol Chem. 286:17365–17375. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kumar S and Gupta S: Thymosin beta 4
prevents oxidative stress by targeting antioxidant and
anti-apoptotic genes in cardiac fibroblasts. PLoS One.
6:e269122011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dai B, Cui M, Zhu M, et al: STAT1/3 and
ERK1/2 synergistically regulate cardiac fibrosis induced by high
glucose. Cell Physiol Biochem. 32:960–971. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cao Y, Xu W and Xiong S: Adoptive transfer
of regulatory T cells protects against coxsackievirus B3-induced
cardiac fibrosis. PLoS One. 8:e749552013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kazakov A, Hall R, Jagoda P, et al:
Inhibition of endothelial nitric oxide synthase induces and
enhances myocardial fibrosis. Cardiovasc Res. 100:211–221. 2013.
View Article : Google Scholar
|
|
52
|
Hou X, Zhang Y, Shen YH, et al: PPAR-γ
activation by rosiglitazone suppresses angiotensin II-mediated
proliferation and phenotypictransition in cardiac fibroblasts via
inhibition of activation of activator protein 1. Eur J Pharmacol.
715:196–203. 2013.
|
|
53
|
Sirish P, Li N, Liu JY, et al: Unique
mechanistic insights into the beneficial effects of soluble epoxide
hydrolase inhibitors in the prevention of cardiac fibrosis. Proc
Natl Acad Sci USA. 110:5618–5623. 2013. View Article : Google Scholar
|
|
54
|
González A, Ravassa S, Beaumont J, López B
and Díez J: New targets to treat the structural remodeling of the
myocardium. J Am Coll Cardiol. 58:1833–1843. 2011.PubMed/NCBI
|
|
55
|
Campbell SE, Janicki JS and Weber KT:
Temporal differences in fibroblast proliferation and phenotype
expression in response to chronic administration of angiotensin II
or aldosterone. J Mol Cell Cardiol. 27:1545–1560. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Porter KE and Turner NA: Cardiac
fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther.
123:255–278. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Burstein B, Libby E, Calderone A and
Nattel S: Differential behaviors of atrial versus ventricular
fibroblasts: a potential role for platelet-derived growth factor in
atrial-ventricular remodeling differences. Circulation.
117:1630–1641. 2008. View Article : Google Scholar
|
|
58
|
Weber KT, Sun Y, Bhattacharya SK, Ahokas
RA and Gerling IC: Myofibroblast-mediated mechanisms of
pathological remodelling of the heart. Nat Rev Cardiol. 10:15–26.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Salimath AS, Phelps EA, Boopathy AV, et
al: Dual delivery of hepatocyte and vascular endothelial growth
factors via a protease-degradable hydrogel improves cardiac
function in rats. PLoS One. 7:e509802012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Lu F, Zhao X, Wu J, et al: MSCs
transfected with hepatocyte growth factor or vascular endothelial
growth factor improve cardiac function in the infarcted porcine
heart by increasing angiogenesis and reducing fibrosis. Int J
Cardiol. 167:2524–2532. 2013. View Article : Google Scholar
|
|
61
|
Guo YH, He JG, Wu JL, et al: Hepatocyte
growth factor and granulocyte colony-stimulating factor form a
combined neovasculogenic therapy for ischemic cardiomyopathy.
Cytotherapy. 10:857–867. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Lo RS, Wotton D and Massagué J: Epidermal
growth factor signaling via Ras controls the Smad transcriptional
co-repressor TGIF. EMBO J. 20:128–136. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Yang J, Dai C and Liu Y: Hepatocyte growth
factor suppresses renal interstitial myofibroblast activation and
intercepts Smad signal transduction. Am J Pathol. 163:621–632.
2003. View Article : Google Scholar : PubMed/NCBI
|
